SQI Diagnostics Inc SQIDF

RaliDx for Pneumonia

[Lotofgold]

https://erj.ersjournals.com/content/erj/early/2022/07/27/13993003.00459-2022.full.pdf

A biomarker assay to risk-stratify patients with symptoms of respiratory tract infection

Shahid Husain, Andrew T. Sage, Lorenzo del Sorbo, Marcelo Cypel, Tereza Martinu, Stephen C. Juvet, Andrea Mariscal, Julie Wright, Bonnie T. Chao, Alaa A. Shamandy, S. Hossein Mousavi, Jin Ma, Bo Wang, Jerome Valero, Mingyao Liu, Megan Landes, Sharaniyaa Balachandran, Kimberley Hudson, Michelle Ngai, Marialessia Capuano, Maria Gelardi, Enrico Lupia, Daniel R. Marinowic, Frederico O. Friedrich, Carine R.R. Schmitz, Leticya S.M. dos Santos, Florencia M. Barbe-Tuana, Marcus H. Jones, Kevin C. Kain, Tony Mazzulli, Sam Sabbah, Shaf Keshavjee

Please cite this article as: Husain S, Sage AT, del Sorbo L, et al. A biomarker assay to risk- stratify patients with symptoms of respiratory tract infection. Eur Respir J 2022; in press (https://doi.org/10.1183/13993003.00459-2022).

This manuscript has recently been accepted for publication in the European Respiratory Journal. It is published here in its accepted form prior to copyediting and typesetting by our production team. After these production processes are complete and the authors have approved the resulting proofs, the article will move to the latest issue of the ERJ online.

Copyright ©The authors 2022. For reproduction rights and permissions contact [e-mail]

[FactFinder1994]

Excellent paper!  Seems unconscionable, that we are approaching what is likley to be a very challanging respiratory fall and winter season where resources are limited and lives are at stake, with the RALI-Dx submission to HC back in November of 2021, and it is not yet being used to help all those in need.  Important tool to have in the tool box, especially at a time like this

[FactFinder1994]

Here are a few paragraphs from recent paper on RALI-Dx  Take Home Message: The RALI-Dx assay is a biomarker-based approach to emergency department triage for patients with respiratory illness and is superior to conventional strategies. This diagnostic test will help to optimize the utilization of scarce healthcare resources. Conclusions: The rapid diagnostic biomarker panel